GE Healthcare Acquires U-Systems, Inc.; Expands GE Presence in Breast Cancer Detection

  GE Healthcare Acquires U-Systems, Inc.; Expands GE Presence in Breast Cancer
  Detection

Breakthrough ultrasound technology complements GE’s portfolio of breast care
innovations

Business Wire

WAUWATOSA, Wis. & SUNNYVALE, Calif. -- November 09, 2012

GE Healthcare, the healthcare division of General Electric (NYSE: GE),
announced today the acquisition of U-Systems, Inc., a manufacturer of
ultrasound products specifically designed for breast applications. With
operations in Sunnyvale, CA and Phoenix, AZ, U-Systems, Inc. has developed the
somo•v® Automated Breast Ultrasound (ABUS), the first and only ultrasound
system on the market approved in the U.S. for breast cancer screening as an
adjunct to mammography for asymptomatic women with greater than 50 percent
dense breast tissue and no prior breast interventions. Financial terms were
not disclosed.

“The combination of U-Systems, Inc. and GE Healthcare uniquely positions GE to
offer U.S. healthcare providers and their patients the most comprehensive
portfolio of breast care innovations on the market - from screening to
diagnosis to monitoring,” said Tom Gentile, president and CEO of GE Healthcare
Systems. “In addition to digital mammography and breast MR, GE can now offer
breast screening ultrasound technology to our customers to help in early
detection - which provides for more treatment options.”

According to a published study in the New England Journal of Medicine, women
with dense tissue in 75% or more of the breast have a risk of breast cancer
four to six times as great as the risk among women with little or no dense
tissue.^1 Since dense breast tissue decreases mammography’s effectiveness in
detection, the somo•v^® ABUS has proven to be a tremendous advancement in the
visualization of cancer-hiding tissue in dense breasts.

“What 3D ultrasound will allow us to do is to help us use the information that
we get from mammography and integrate that information together with the
information we get from ultrasound to find more cancers,” said Dr. Rachel
Brem, M.D., the Principal investigator of the SOMO-INSIGHT clinical study
examining whether Full Field Digital Mammography along with the somo•v® could
improve breast cancer detection when compared to mammography alone in women
with dense breasts. “Mammography is an effective tool at finding breast
cancer, but it doesn’t work equally well in everyone. Recently completed
studies demonstrated with the addition of somo•v® ABUS we find about 30
percent more cancers in women who have a normal mammogram, normal physical
examination and dense breasts. For the more than 40 percent of women who have
dense breasts, this is a significant advancement in their breast healthcare.”

The somo•v^® ABUS received approval by the Food and Drug Administration (FDA)
in September 2012 for breast cancer screening in the United States, and has
also been indicated for screening in Canada and the European Union.

“We are very excited to become part of GE Healthcare's team,” said Ron Ho,
U-Systems President and CEO. “The worldwide resources of GE Healthcare will
allow us to expand and accelerate our efforts to commercialize the recently
FDA-Approved somo•v® ABUS. With our combined resources and capabilities, we
have the opportunity to make a significant impact on breast cancer detection
and patient outcomes around the world. We are thrilled to have the opportunity
to continue to develop new technologies, products and applications for breast
cancer screening. The entire U-Systems team looks forward to joining GE.”

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that
are shaping a new age of patient care. Our broad expertise in medical imaging
and information technologies, medical diagnostics, patient monitoring systems,
drug discovery, biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our customers to deliver
better care to more people around the world at a lower cost. In addition, we
partner with healthcare leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable healthcare systems.

Our “healthymagination” vision for the future invites the world to join us on
our journey as we continuously develop innovations focused on reducing costs,
increasing access and improving quality around the world. Headquartered in the
United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE:
GE). Worldwide, GE Healthcare employees are committed to serving healthcare
professionals and their patients in more than 100 countries.
www.gehealthcare.com. For our latest news, please visit
http://newsroom.gehealthcare.com/.

About U-Systems

As the leader in automated breast ultrasound, U-Systems is establishing the
standard for breast ultrasound screening. For more information about
U-Systems, please visit our website at: http://www.u-systems.com.

^1 Boyd, et al. New England Journal of Medicine 2007;356:227-36M

Contact:

GE Healthcare
Arvind Gopalratnam, 262-501-0777
Arvind.gopalratnam@ge.com
or
Brian McKaig, 414-477-6522
brian.mckaig@ge.com